| Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences (NCT04819737) | University Hospital, Basel, Switzerland | 2022-07-18 |
| A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis (NCT05064436) | Bristol-Myers Squibb | 2021-12-10 |
| Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NCT04926818) | Novartis Pharmaceuticals | 2021-10-05 |
| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders (NCT05000216) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-13 |
| Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis (NCT04777539) | Nantes University Hospital | 2021-06-14 |
| MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study (NCT05058729) | Biogen | 2020-12-07 |
| Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (NCT04602390) | Anokion SA | 2020-11-06 |
| Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis (NCT04203498) | Jazz Pharmaceuticals | 2020-10-01 |
| A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis (NCT04121468) | The Hospital for Sick Children | 2020-02-24 |
| Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) (NCT03961204) | EMD Serono Research & Development Institute, Inc. | 2019-08-15 |
| A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis (NCT03972306) | Hoffmann-La Roche | 2019-08-12 |
| A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis (NCT03737812) | AbbVie | 2019-02-27 |
| A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis (NCT03737851) | AbbVie | 2018-12-11 |
| Chronic Inflammatory Disease, Lifestyle and Risk of Disease (NCT03456206) | University of Southern Denmark | 2018-11-10 |
| Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study (NCT03624296) | Assistance Publique Hopitaux De Marseille | 2018-10-01 |
| Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis (NCT05177523) | University Hospital, Basel, Switzerland | 2018-09-04 |
| Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis (NCT03135249) | University of Texas Southwestern Medical Center | 2018-05-01 |
| Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography (NCT04705610) | Association de Recherche Bibliographique pour les Neurosciences | 2017-05-23 |
| Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) (NCT02739542) | University of Texas Southwestern Medical Center | 2016-03-19 |
| Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study (NCT02695394) | Charite University, Berlin, Germany | 2016-02-01 |
| An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis (NCT02612935) | Lumos Labs, Inc. | 2015-03-01 |
| Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis (NCT02166021) | Dimitrios Karussis | 2015-01-29 |
| Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis (NCT02352194) | Assistance Publique - Hôpitaux de Paris | 2014-07-01 |
| Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases (NCT02308579) | University at Buffalo | 2014-07-01 |
| Electric Stimulation of the Eye to Improve Vision After Trauma (NCT02019927) | Wills Eye | 2013-07-01 |
| Alternative Treatment Paradigm for Natalizumab Trial (NCT01710228) | University of Texas Southwestern Medical Center | 2013-07-01 |
| Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations (NCT01888354) | The University of Texas Health Science Center, Houston | 2013-04-01 |
| Pregnancy Cohort in Multiple Sclerosis (MS) (NCT05010902) | Charite University, Berlin, Germany | 2013-01-01 |
| Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (NCT01804647) | GeNeuro Innovation SAS | 2012-11-01 |
| Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients (NCT01952483) | American University of Beirut Medical Center | 2012-08-01 |
| PRISM Registry: Pseudobulbar Affect Registry Series (NCT01366027) | Avanir Pharmaceuticals | 2011-05-01 |
| The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System. (NCT01567553) | Rennes University Hospital | 2009-04-01 |
| Avonex®: Safety, Blood Levels and Effects (NCT01863069) | Trio Medicines Ltd. | 2001-01-01 |